DOCSLIB.ORG

Diagnosis Codes in the Behavioral Health Services Reporting Classification Chart (BHSRCC)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Provider Bulletin 07-01 Philadelphia Department of Behavioral Health Community Behavioral Health State Allowable ICD-9-CM Codes. February 12, 2007 The Commonwealth of Pennsylvania lists the allowable ICD-9-CM (International Classification of Disease 9th Revision, Clinical Modification) diagnosis codes in the Behavioral Health Services Reporting Classification Chart (BHSRCC). The BHSRCC is published and provided to CBH twice a year. The chart listed below contains the only allowable diagnosis codes as of January 1, 2007. This chart will be enforced via the CBH claims system as of March 15, 2007. The chart is currently available on the CBH website http://www.phila-bhs.org/providers.html. All future modifications to this chart will be published on the CBH website and providers will have the responsibility to check the website for any changes. At the current time the Commonwealth updates the BHSRCC in January and July. When using a diagnosis code please make sure that the number of digits after decimal point is correct and correspond to the one of the codes on the chart below. For example, when the diagnosis is “Senile dementia, uncomplicated” please ensure that the code 290.0 is used, not 290 or 290.00. Likewise, if a diagnosis code requires two digits after the decimal point – both digits must be present. For instance, diagnosis “Presenile dementia, uncomplicated” must be coded as 290.10, not as 290.1. List of ICD-9-CM codes appropriate for billing (Behavioral Health Services Classification Chart, January 2007). Dementias 290.0 Senile dementia, uncomplicated Presenile dementia 290.10 Presenile dementia, uncomplicated 290.11 Presenile dementia with delirium 290.12 Presenile dementia with delusional features 290.13 Presenile dementia with depressive features Senile dementia with delusional or depressive features 290.20 Senile dementia with delusional features 290.21 Senile dementia with depressive features 290.3 Senile dementia with delirium Vascular dementia 290.40 Vascular dementia, uncomplicated 290.41 Vascular dementia with delirium 290.42 Vascular dementia with delusions 290.43 Vascular dementia with depressed mood *Code was added beginning 01/01/2006 1 of 14 290.8 Other specified senile psychotic conditions 290.9 Unspecified senile psychotic condition Alcohol-induced mental disorders 291.0 Alcohol withdrawal delirium 291.1 Alcohol-induced persisting amnestic syndrome 291.2 Alcohol-induced persisting dementia 291.3 Alcohol-induced psychotic disorder with hallucinations 291.4 Idiosyncratic alcohol intoxication 291.5 Alcohol-induced psychotic disorder with delusions Other specified alcoholic psychosis 291.81 Alcohol withdrawal 291.82* Alcohol induced sleep disorders 291.89 Other 291.9 Unspecified alcohol-induced mental disorder Drug-induced mental disorder 292.0 Drug withdrawal Drug-induced psychotic disorders 292.11 Drug-induced psychotic disorder with delusions 292.12 Drug-induced psychotic disorder with delusions hallucinations 292.2 Pathological drug intoxication Other specified drug-induced mental disorders 292.81 Drug-induced delirium 292.82 Drug-induced persisting dementia 292.83 Drug-induced persisting amnestic disorder 292.84 Drug-induced mood disorder 292.85* Drug-induced sleep disorders 292.89 Other 292.9 Unspecified drug-induced mental disorder Transient mental disorders due to conditions classified elsewhere 293.0 Delirium due to conditions classified elsewhere 293.1 Subacute delirium Other specified transient mental disorders due to conditions classified elsewhere 293.81 Psychotic disorder with delusions in conditions classified elsewhere 293.82 Psychotic disorder with hallucinations in conditions classified elsewhere 293.83 Mood disorder in conditions classified elsewhere 293.84 Anxiety disorder in conditions classified elsewhere 293.89 Other 293.9 Unspecified transient mental disorder in conditions classified elsewhere Persistent mental disorders due to conditions classified elsewhere 294.0 Amnestic disorder in conditions classified elsewhere *Code was added beginning 01/01/2006 2 of 14 Dementia in conditions classified elsewhere 294.10 Dementia in conditions classified elsewhere without behavioral disturbance 294.11 Dementia in conditions classified elsewhere with behavioral disturbance 294.8 Other persistent mental disorders due to conditions classified elsewhere 294.9 Unspecified persistent mental disorders due to conditions classified elsewhere Schizophrenic disorders Simple type 295.00 0 – Unspecified 295.01 1 – Subchronic 295.02 2 – Chronic 295.03 3 - Subchronic with acute exacerbation 295.04 4 - Chronic with acute exacerbation 295.05 5 - In remission Disorganized type 295.10 0 – Unspecified 295.11 1 – Subchronic 295.12 2 – Chronic 295.13 3 - Subchronic with acute exacerbation 295.14 4 - Chronic with acute exacerbation 295.15 5 - In remission Catatonic type 295.20 0 – Unspecified 295.21 1 – Subchronic 295.22 2 – Chronic 295.23 3 - Subchronic with acute exacerbation 295.24 4 - Chronic with acute exacerbation 295.25 5 - In remission Paranoid type 295.30 0 – Unspecified 295.31 1 – Subchronic 295.32 2 – Chronic 295.33 3 - Subchronic with acute exacerbation 295.34 4 - Chronic with acute exacerbation 295.35 5 - In remission Schizophreniform disorder 295.40 0 – Unspecified 295.41 1 – Subchronic 295.42 2 – Chronic 295.43 3 - Subchronic with acute exacerbation 295.44 4 - Chronic with acute exacerbation 295.45 5 - In remission Latent schizophrenia 295.50 0 – Unspecified 295.51 1 – Subchronic 295.52 2 – Chronic 295.53 3 - Subchronic with acute exacerbation *Code was added beginning 01/01/2006 3 of 14 295.54 4 - Chronic with acute exacerbation 295.55 5 - In remission Residual type 295.60 0 – Unspecified 295.61 1 – Subchronic 295.62 2 – Chronic 295.63 3 - Subchronic with acute exacerbation 295.64 4 - Chronic with acute exacerbation 295.65 5 - In remission Schizoaffective disorder 295.70 0 – Unspecified 295.71 1 – Subchronic 295.72 2 – Chronic 295.73 3 - Subchronic with acute exacerbation 295.74 4 - Chronic with acute exacerbation 295.75 5 - In remission Other specified types of schizophrenia 295.80 0 – Unspecified 295.81 1 – Subchronic 295.82 2 – Chronic 295.83 3 - Subchronic with acute exacerbation 295.84 4 - Chronic with acute exacerbation 295.85 5 - In remission Unspecified schizophrenia 295.90 0 – Unspecified 295.91 1 – Subchronic 295.92 2 – Chronic 295.93 3 - Subchronic with acute exacerbation 295.94 4 – Chronic with acute exacerbation 295.95 5 - In remission Episodic mood disorders Bipolar I disorder, single manic episode 296.00 0 - Unspecified 296.01 1 – Mild 296.02 2 - Moderate 296.03 3 - Severe, without mention of psychotic behavior 296.04 4 - Severe, specified as with psychotic behavior 296.05 5 - In partial or unspecified remission 296.06 6 - In full remission Manic disorder, recurrent episode 296.10 0 - Unspecified 296.11 1 – Mild 296.12 2 - Moderate 296.13 3 - Severe, without mention of psychotic behavior 296.14 4 - Severe, specified as with psychotic behavior 296.15 5 - In partial or unspecified remission 296.16 6 - In full remission *Code was added beginning 01/01/2006 4 of 14 Major depressive disorder, single episode 296.20 0 - Unspecified 296.21 1 – Mild 296.22 2 - Moderate 296.23 3 - Severe, without mention of psychotic behavior 296.24 4 - Severe, specified as with psychotic behavior 296.25 5 - In partial or unspecified remission 296.26 6 - In full remission Major depressive disorder, recurrent episode 296.30 0 - Unspecified 296.31 1 – Mild 296.32 2 - Moderate 296.33 3 - Severe, without mention of psychotic behavior 296.34 4 - Severe, specified as with psychotic behavior 296.35 5 - In partial or unspecified remission 296.36 6 - In full remission Bipolar I disorder, most recent episode (or current) manic 296.40 0 - Unspecified 296.41 1 – Mild 296.42 2 - Moderate 296.43 3 - Severe, without mention of psychotic behavior 296.44 4 - Severe, specified as with psychotic behavior 296.45 5 - In partial or unspecified remission 296.46 6 - In full remission Bipolar I disorder, most recent episode (or current) depressed 296.50 0 - Unspecified 296.51 1 – Mild 296.52 2 - Moderate 296.53 3 - Severe, without mention of psychotic behavior 296.54 4 - Severe, specified as with psychotic behavior 296.55 5 - In partial or unspecified remission 296.56 6 - In full remission Bipolar I disorder, most recent episode (or current) mixed 296.60 0 - Unspecified 296.61 1 – Mild 296.62 2 - Moderate 296.63 3 - Severe, without mention of psychotic behavior 296.64 4 - Severe, specified as with psychotic behavior 296.65 5 - In partial or unspecified remission 296.66 6 - In full remission 296.7 Bipolar I disorder, most recent episode (or current) unspecified Other and unspecified bipolar disorders 296.80 Bipolar disorder, unspecified 296.81 Atypical manic disorder 296.82 Atypical depressive disorder 296.89 Other *Code was added beginning 01/01/2006 5 of 14 Other and unspecified episodic mood disorder 296.90 Unspecified episodic mood disorder 296.99 Other specified episodic mood disorder Delusional disorders 297.0 Paranoid state, simple 297.1 Delusional disorder 297.2 Paraphrenia 297.3 Shared psychotic disorder 297.8 Other specified paranoid states 297.9 Unspecified paranoid state Other nonorganic psychoses 298.0 Depressive type psychosis 298.1 Excitative type psychosis 298.2 Reactive confusion 298.3 Acute paranoid reaction 298.4 Psychogenic paranoid psychosis 298.8 Other and unspecified reactive psychosis 298.9 Unspecified psychosis Pervasive developmental disorders Autistic disorder 299.00 0 - Current or active state 299.01 1
Recommended publications
  • Diagnostic and Management Guidelines for Mental Disorders in Primary Care

    Diagnostic and Management Guidelines for Mental Disorders in Primary Care

    Diagnostic and Management Guidelines for Mental Disorders in Primary Care ICD-10 Chapter V ~rimary Care Version Published on behalf of the World Health Organization by Hogrefe & Huber Publishers World Health Organization Hogrefe & Huber Publishers Seattle . Toronto· Bern· Gottingen Library of Congress Cataloging-in-Publication Data is available via the Library of Congress Marc Database under the LC Catalog Card Number 96-77394 Canadian Cataloguing in Publication Data Main entry under title: Diagnostic and management guidelines for mental disorders in primary care: ICD-lO chapter V, primary care version ISBN 0-88937-148-2 1. Mental illness - Classification. 2. Mental illness - Diagnosis. 3. Mental illness - Treatment. I. World Health Organization. 11. Title: ICD-ten chapter V, primary care version. RC454.128 1996 616.89 C96-931353-5 The correct citation for this book should be as follows: Diagnostic and Management Guidelines for Mental Disorders in Primary Care: ICD-lO Chapter V Primary Care Version. WHO/Hogrefe & Huber Publishers, Gottingen, Germany, 1996. © Copyright 1996 by World Health Organization All rights reserved. Hogrefe & Huber Publishers USA: P.O. Box 2487, Kirkland, WA 98083-2487 Phone (206) 820-1500, Fax (206) 823-8324 CANADA: 12 Bruce Park Avenue, Toronto, Ontario M4P 2S3 Phone (416) 482-6339 SWITZERLAND: Langgass-Strasse 76, CH-3000 Bern 9 Phone (031) 300-4500, Fax (031) 300-4590 GERMANY: Rohnsweg 25,0-37085 Gottingen Phone (0551) 49609-0, Fax (0551) 49609-88 No part of this book may be translated, reproduced, stored in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photocopying, microfilming, recording or otherwise, without the written permission from the copyright holder.
  • Mental Health Diagnosis Codes

    Mental Health Diagnosis Codes

    Mental Health Diagnosis Codes Code Description Code System 10007009 Coffin-Siris syndrome (disorder) SNOMEDCT 10278007 Factitious purpura (disorder) SNOMEDCT 10327003 Cocaine-induced mood disorder (disorder) SNOMEDCT 10349009 Multi-infarct dementia with delirium (disorder) SNOMEDCT 10532003 Primary degenerative dementia of the Alzheimer type, presenile onset, with SNOMEDCT depression (disorder) 10586006 Occupation-related stress disorder (disorder) SNOMEDCT 106013002 Mental disorder of infancy, childhood or adolescence (disorder) SNOMEDCT 106014008 Organic mental disorder of unknown etiology (disorder) SNOMEDCT 106015009 Mental disorder AND/OR culture bound syndrome (disorder) SNOMEDCT 109006 Anxiety disorder of childhood OR adolescence (disorder) SNOMEDCT 109478007 Kohlschutter's syndrome (disorder) SNOMEDCT 109805003 Factitious cheilitis (disorder) SNOMEDCT 109896009 Indication for modification of patient status (disorder) SNOMEDCT 109897000 Indication for modification of patient behavior status (disorder) SNOMEDCT 109898005 Indication for modification of patient cognitive status (disorder) SNOMEDCT 109899002 Indication for modification of patient emotional status (disorder) SNOMEDCT 109900007 Indication for modification of patient physical status (disorder) SNOMEDCT 109901006 Indication for modification of patient psychological status (disorder) SNOMEDCT 11061003 Psychoactive substance use disorder (disorder) SNOMEDCT 111475002 Neurosis (disorder) SNOMEDCT 111476001 Mental disorder usually first evident in infancy, childhood AND/OR
  • Icd-9-Cm Mental Disorders Diagnosis Codes And

    Icd-9-Cm Mental Disorders Diagnosis Codes And

    ATTACHMENT A ICD-9-CM MENTAL DISORDERS DIAGNOSIS CODES AND DESCRIPTIONS Subject to Certification of Admission/Concurrent/Continued Stay Review Revised Effective May 1, 2005 Effective Dates of New Codes Are Noted in Bold After Their Description This list contains principal diagnosis codes for psychiatric services Category of Service 21. General care hospitals that are not enrolled for COS 21 will continue to bill for a maximum of three days of emergency psychiatric care using COS 20. Schizophrenic disorders 295.00 Unspecified 295.01 Subchronic 295.02 Chronic 295.03 Subchronic with acute exacerbation 295.04 Chronic with acute exacerbation 295.05 In remission 295.10 Disorganized type unspecified 295.11 Disorganized type subchronic 295.12 Disorganized type chronic 295.13 Disorganized type subchronic with acute exacerbation 295.14 Disorganized type chronic with acute exacerbation 295.15 Disorganized type in remission 295.20 Catatonic type unspecified 295.21 Catatonic type subchronic 295.22 Catatonic type chronic 295.23 Catatonic type subchronic with acute exacerbation 295.24 Catatonic type chronic with acute exacerbation 295.25 Catatonic type in remission 295.30 Paranoid type unspecified 295.31 Paranoid type subchronic 295.32 Paranoid type chronic 295.33 Paranoid type subchronic with acute exacerbation 295.34 Paranoid type chronic with acute exacerbation 295.35 Paranoid type in remission 295.40 Schizophreniform disorder, unspecified 295.41 Schizophreniform disorder, subchronic 295.42 Schizophreniform disorder, chronic 295.43 Schizophreniform
  • Vaginismus: the Sexual Disorder You've Never Heard of It Affects 5 to 17 Percent of Women

    Vaginismus: the Sexual Disorder You've Never Heard of It Affects 5 to 17 Percent of Women

    Vaginismus: The Sexual Disorder You've Never Heard Of It affects 5 to 17 percent of women. Chances are you've never heard of vaginismus (or, as it is now known, genitopelvic pain penetration disorder) before. Why? Because it's the disorder nobody wants to talk about, least of all those whom it most affects -- women. Quite amazing when you take into account it affects 5 to 17 percent of women (though even those statistics are tricky, considering how hush-hush the whole topic has become) and is the primary female cause of sexless (unconsummated) marriages. Not only is GPPPD rarely discussed among sufferers, but it appears to be largely neglected in the medical world, too. According to relationship counsellor and sex therapist, Alinda Small, the condition is "rarely taught in medical schools and residencies or discussed at medical conferences." So what is GPPPD and why is it shrouded in so much secrecy? What is vaginismus (GPPPD)? "Basically it's the involuntary contraction of muscles surrounding the entrance to the vagina," Small told The Huffington Post Australia. "What happens is the muscles lock up -- and they are incredibly strong -- and nothing can penetrate through. You can't get a finger, a tampon or a Q tip in, let alone a penis. "Women don't talk about it and they don't come forward for treatment." According to Small, there are two main types of GPPPD; primary and secondary. "Primary vaginismus is something you have had your entire life, where you have never been able to insert anything into the vagina," Small said.
  • Factors That Might Be Predictive of Completion of Vaginismus Treatment 2 Kadir ÖZDEL1, Ayşegül YILMAZ ÖZPOLAT2, Özge ÇERİ3, Hakan KUMBASAR4

    Factors That Might Be Predictive of Completion of Vaginismus Treatment 2 Kadir ÖZDEL1, Ayşegül YILMAZ ÖZPOLAT2, Özge ÇERİ3, Hakan KUMBASAR4

    Turkish Journal of Psychiatry 2012 Factors That Might Be Predictive of Completion of Vaginismus Treatment 2 Kadir ÖZDEL1, Ayşegül YILMAZ ÖZPOLAT2, Özge ÇERİ3, Hakan KUMBASAR4 SUMMARY Objective: Vaginismus is defined as a recurrent or persistent involuntary spasm of the musculature of the outer third of the vagina that interferes with sexual intercourse. The aim of this study was to assess the level of symptoms of depression, anxiety, obsessive-compulsive symptoms, and perfection- ism among patients with vaginismus, as well as to determine if these clinical variables are related to the completion of treatment. Materials and Methods: The study included 20 women with vaginismus and their spouses that were referred as outpatients to Ankara University, School of Medicine, Department of Psychiatry, Consultation and Liaison Unit. All couples underwent cognitive behavioral therapy, which was administered as 40-60-min weekly sessions. At the first (assessment) session, the female patients were assessed using a sociodemographic evaluation form, the Hamilton Rating Scale for Depression (HAM-D), the Hamilton Rating Scale for Anxiety (HAM-A), the Maudsley Obsessive-Compulsive Inventory (MOCI), the Multidimensional Perfectionism Scale (MPS), and the Golombok Rust Inventory of Sexual Satisfaction (GRISS). The male spouses were evaluated using the GRISS. The same scales were administered after the completion of treatment to those that completed the treatment. Results: The correlation between completion of treatment, and an elevated level of anxiety and self-oriented perfectionism was significant (P < 0.05). Among those that completed the study, depressive symptoms in the female patients improved (P < 0.05), and scale scores related to sexual function- ing in both the males and females improved significantly (P < 0.05).
  • The ICD-10 Classification of Mental and Behavioural Disorders : Clinical Descriptions and Diagnostic Guidelines

    The ICD-10 Classification of Mental and Behavioural Disorders : Clinical Descriptions and Diagnostic Guidelines

    ICD-10 ThelCD-10 Classification of Mental and Behavioural Disorders Clinical descriptions and diagnostic guidelines | World Health Organization I Geneva I 1992 Reprinted 1993, 1994, 1995, 1998, 2000, 2002, 2004 WHO Library Cataloguing in Publication Data The ICD-10 classification of mental and behavioural disorders : clinical descriptions and diagnostic guidelines. 1.Mental disorders — classification 2.Mental disorders — diagnosis ISBN 92 4 154422 8 (NLM Classification: WM 15) © World Health Organization 1992 All rights reserved. Publications of the World Health Organization can be obtained from Marketing and Dissemination, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel: +41 22 791 2476; fax: +41 22 791 4857; email: [email protected]). Requests for permission to reproduce or translate WHO publications — whether for sale or for noncommercial distribution — should be addressed to Publications, at the above address (fax: +41 22 791 4806; email: [email protected]). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers' products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters.
  • Search Strategy for Mental Health Conditions After Snakebite : Scoping Review

    Search Strategy for Mental Health Conditions After Snakebite : Scoping Review

    BMJ Publishing Group Limited (BMJ) disclaims all liability and responsibility arising from any reliance Supplemental material placed on this supplemental material which has been supplied by the author(s) BMJ Global Health Supplementary Material 2 : Search Strategy for Mental Health conditions after snakebite : Scoping review Database: Ovid MEDLINE(R) <1946 to April 09, 2020> Search Strategy: -------------------------------------------------------------------------------- 1 exp Snake Bites/ (4584) 2 Snakebit*.mp. (1864) 3 ((bite* or envenom*) adj3 Snake*).mp. (5156) 4 1 or 2 or 3 (5470) 5 SELF-INJURIOUS BEHAVIOR/ or SELF MUTILATION/ or SUICIDE/ or SUICIDAL IDEATION/ or SUICIDE, ATTEMPTED/ (64456) 6 MOOD DISORDERS/ or AFFECTIVE DISORDERS, PSYCHOTIC/ or BIPOLAR DISORDER/ or CYCLOTHYMIC DISORDER/ or DEPRESSIVE DISORDER/ or DEPRESSIVE DISORDER, MAJOR/ or DEPRESSIVE DISORDER, TREATMENT-RESISTANT/ or DYSTHYMIC DISORDER/ (145622) 7 NEUROTIC DISORDERS/ (17971) 8 DEPRESSION/ (116351) 9 ADJUSTMENT DISORDERS/ (4201) 10 ANXIETY DISORDERS/ or AGORAPHOBIA/ or OBSESSIVE-COMPULSIVE DISORDER/ or OBSESSIVE HOARDING/ or PANIC DISORDER/ or PHOBIC DISORDERS/ or STRESS DISORDERS, TRAUMATIC/ or COMBAT DISORDERS/ or STRESS DISORDERS, POST- TRAUMATIC/ or STRESS DISORDERS, TRAUMATIC, ACUTE/ (91419) 11 ANXIETY/ or PANIC/ or HYSTERIA/ (84842) 12 MUNCHAUSEN SYNDROME BY PROXY/ or MUNCHAUSEN SYNDROME/ (1800) 13 FATIGUE SYNDROME, CHRONIC/ or OBSESSIVE BEHAVIOR/ (6634) 14 COMPULSIVE BEHAVIOR/ or BEHAVIOR, ADDICTIVE/ or IMPULSE CONTROL DISORDERS/ (14628) 15 STRESS, PSYCHOLOGICAL/
  • The ICD-10 Classification of Mental and Behavioural Disorders Diagnostic Criteria for Research

    The ICD-10 Classification of Mental and Behavioural Disorders Diagnostic Criteria for Research

    The ICD-10 Classification of Mental and Behavioural Disorders Diagnostic criteria for research World Health Organization Geneva The World Health Organization is a specialized agency of the United Nations with primary responsibility for international health matters and public health. Through this organization, which was created in 1948, the health professions of some 180 countries exchange their knowledge and experience with the aim of making possible the attainment by all citizens of the world by the year 2000 of a level of health that will permit them to lead a socially and economically productive life. By means of direct technical cooperation with its Member States, and by stimulating such cooperation among them, WHO promotes the development of comprehensive health services, the prevention and control of diseases, the improvement of environmental conditions, the development of human resources for health, the coordination and development of biomedical and health services research, and the planning and implementation of health programmes. These broad fields of endeavour encompass a wide variety of activities, such as developing systems of primary health care that reach the whole population of Member countries; promoting the health of mothers and children; combating malnutrition; controlling malaria and other communicable diseases including tuberculosis and leprosy; coordinating the global strategy for the prevention and control of AIDS; having achieved the eradication of smallpox, promoting mass immunization against a number of other
  • Acute Stress Disorder, 59 Affect, 30-31, 111 Ageism, 374

    Acute Stress Disorder, 59 Affect, 30-31, 111 Ageism, 374

    Index Acute stress disorder, 59 Delusions, 34-35, 111-·112 Affect, 30-31, 111 Dependent personality disorder, 144-145, 218- Ageism, 374 219 Agoraphobia, 56-57 Drug abuse, 189-208 Alcohol problems, 155-182 case illustration, 201-207 case illustrations, 169-175 description of, 189-191 description oE, 155-158 obtaining information, 192-198 diagnosis of, 175-178 Drug dependence, 190-191 obtaining information, 158-169 Dyspareunia, 212 Amnesia, 348 Dysthymic disorder, 80, 92-95 Anorexia nervosa, 242-243 Antisocial personality disorder, 134-137 Eating disorders, 241-255 Anxiety disorders, 55-74 case illustrations, 247-249 case illustration, 64-72 description of, 241-245 description of, 55-59 obtaining information, 246-247 obtaining information, 59-64 Echolalia, 32 Anxious depressions, 86-88 Echopraxia, 32 Aphonia, 33 Emergency settings, 4-6 Attention, 38 Essential hypertension, 266-268 Avoidant personality disorder, 144 Ethnic considerations, 10-14 Executive functions, 364 Binge eating disorder, 245 Exhibitionism, 214 Bipolar disorder, 80-81, 89-92 Borderline personality disorder, 138-141, 217- Female orgasmic disorder, 212 218 Female sexual arousal disorder, 211 Bulimia nervosa, 243-245 Fetishism, 214 Formal thought disorder, 44-45 Children, 305-324 Flight of ideas, 32 case illustration, 320-324 Frontal lobe syndrome, 363-364 description of disorders, 306-307 Frotteurisrn., 214 obtaining information, 307-319 child interview, 312-313 Generalized anxiety disorder, 59 parental interview, 309-312 significantothers, 311-312 Hallucinations, 36-37,
  • The Role of Anxiety in Vaginismus: a Case-Control Studyjsm 1365 1..6

    The Role of Anxiety in Vaginismus: a Case-Control Studyjsm 1365 1..6

    1 The Role of Anxiety in Vaginismus: A Case-Control Studyjsm_1365 1..6 Gayle Watts, BSc, and Daniel Nettle, PhD Newcastle University, Institute of Neuroscience, Newcastle, UK DOI: 10.1111/j.1743-6109.2009.01365.x ABSTRACT Introduction. Previous research suggests that anxiety may play a large role in the symptoms of vaginismus. Aim. We aimed to (i) determine the degree of self-reported general anxiety in women with vaginismus; and (ii) establish whether general anxiety is a consequence of the condition or a predisposing factor. Main Outcome Measures. Participants reported state and trait anxiety, five-factor personality scores, history of anxiety disorders, and their perceptions of their symptoms and history. Methods. We compared responses of 244 self-identified women with vaginismus with a control group of 101 women using an online questionnaire. Results. The women with vaginismus were higher in trait anxiety and neuroticism, and lower in extraversion, than the controls. There was also a trend toward a greater prevalence of diagnosed anxiety disorders in the vaginismus group. Levels of state anxiety were high among the women with vaginismus, particularly when they felt unsupported by their partners or pressured to cure the condition. Conclusion. Levels of general anxiety are elevated among women with vaginismus and the data suggest that anxiety-proneness may be a predisposing factor for the condition. We conclude that although vaginismus is a multidimensional condition, it may have common predisposing factors with anxiety disorders. Watts G, and Nettle D. The role of anxiety in vaginismus: A case-control study. J Sex Med **;**:**–**. Key Words. Vaginismus; Anxiety; Anxiety Disorders; Sexual Pain; Dyspareunia Introduction anxiety, and anxiety is generally accepted as etio- logically important in vaginismus [9].
  • Safety, Tolerability, and Feasibility of Young Plasma

    Safety, Tolerability, and Feasibility of Young Plasma

    Statistical Analysis Plan The PLasma for Alzheimer SymptoM Amelioration (PLASMA) Study (PLASMA) 1 1 Abbreviations and Definitions AE Adverse Event CRF Case Report Form CTCAE Common Terminology Criteria for Adverse Events IMP Investigational Medical Product SAP Statistical Analysis Plan 2 2 Introduction 3 2.1 Preface 4 The Plasma for Alzheimer SymptoM Amelioration (PLASMA) Study: Intravenously- 5 Administered Plasma from Young Donors for Treatment of Mild-To-Moderate 6 Alzheimer’s Disease 7 2.2 Purpose of the analyses 8 These analyses will assess 1) number of subjects with adverse events as a 9 measure of safety and tolerability and number of subjects who comply with 10 the research protocol as a measure of feasibility 2) the neuropsychological, 11 functional and neuropsychiatric outcomes 3) other outcomes such as 12 functional connectivity assessed by resting state functional MRI, 13 compositional assessment of plasma, in vivo assessment of plasma 14 samples, and differential effect of outcomes related to ApoE genotype . 15 3 Study Objectives and Endpoints 16 3.1 Study Objectives 17 The objective of the study is to determine the safety and tolerability and feasibility 18 of once per week infusion of young plasma into this patient population and with 19 experimental endpoints to assess efficacy in cognition, behaviour and mood. 20 3.2 Endpoints 21 The primary outcome measure is the number of subjects with AEs as a measure of 22 safety and tolerability, and number of subjects who comply with the research 23 protocol as a measure of feasibility. Changes from baseline (as derived variables) in Page 1 of 29 Downloaded From: https://jamanetwork.com/ on 10/02/2021 Statistical Analysis Plan The PLasma for Alzheimer SymptoM Amelioration (PLASMA) Study (PLASMA) 24 laboratory parameters (cbc, chemistry, liver function), vital signs, EKG, and physical 25 examination.
  • Alexithymia and Vaginismus: a Preliminary Correlation Perspective

    Alexithymia and Vaginismus: a Preliminary Correlation Perspective

    International Journal of Impotence Research (2013) 25, 113–116 & 2013 Macmillan Publishers Limited All rights reserved 0955-9930/13 www.nature.com/ijir ORIGINAL ARTICLE Alexithymia and vaginismus: a preliminary correlation perspective G Ciocca1, E Limoncin1, S Di Tommaso1, GL Gravina1, S Di Sante1, E Carosa1, A Tullii2, A Marcozzi2, A Lenzi3 and EA Jannini1 The aim of this study was to measure the prevalence of alexithymia and emotional dysregulation in women with vaginismus not associated with other organic or psychopathological disorders. The study involved the psychometric assessment of 41 patients with vaginismus and 100 healthy women, all of childbearing age. Alexithymia was evaluated by TAS-20 (Toronto Alexithymia Scale). Sexual function was assessed by FSFI (Female Sexual Function Index). In patients with vaginismus, the primary diagnosis of dyspareunia was excluded and an expert psychologist evaluated patients and controls according to DSM IV (Diagnostic and Statistical Manual of Mental Disorders: 4th edition) criteria to exclude mental disorders. Over half (51.1%) of the patients with vaginismus were classified as alexithymic or borderline (alexithymic trend), compared with just 18% of the control group. In addition, there was a significant difference in the TAS-20 total scores between the two groups (Po0.0001). In terms of relative risk, women suffering from vaginismus thus have a 3.8 times higher probability of showing alexithymia than do healthy women. Vaginismus is a complex syndrome and alexithymia is far from being its only characteristic. However, we found a significant correlation between vaginismus and alexithymia. In theory, alexithymia could thus be a risk factor for vaginismus, although future studies are required to demonstrate any chain of causation between these two conditions.